1 Nagai T, Matsui H, Fujioka H, Homma Y, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Tomohisa W, Otsuka Y, Nakashima K.
Low-Dose vs Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Not Infected With HIV: A Multicenter, Retrospective Observational Cohort Study.
Chest. 2024 Jan;165(1):58-67. doi: 10.1016/j.chest.2023.08.009. Epub 2023 Aug 11. PMID: 37574166.
2 Ohmura SI, Matsui H, Miyamoto T, Shichi D, Masui T, Ichijo K, Homma Y, Fujioka H, Nagai T, Nakashima K.
Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics.
Respir Investig. 2024 May;62(3):377-383. doi: 10.1016/j.resinv.2024.02.015. Epub 2024 Mar 6. PMID: 38452442.
3 Morimoto Y, Matsui H, Fujioka H, Homma Y, Nagai T, Otsuki A, Ito H, Ohmura SI, Miyamoto T, Shichi D, Watari T, Otsuka Y, Nakashima K.
Effectiveness of pulse methylprednisolone in patients with non-human immunodeficiency virus pneumocystis pneumonia: a multicentre, retrospective registry-based cohort study.
BMC Infect Dis. 2024 Nov 2;24(1):1233. doi: 10.1186/s12879-024-10151-3. PMID: 39488718; PMCID: PMC11531689.
4 Fujioka H, Matsui H, Homma Y, Nagai T, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Tomohisa W, Otsuka Y, Nakashima K.
Association of time-to-treatment with prognosis in pneumocystis pneumonia among immunocompromised patients without HIV infection: a multi-center, retrospective observational cohort study.
BMC Infect Dis. 2025 Apr 15;25(1):531. doi: 10.1186/s12879-025-10933-3. PMID: 40234819; PMCID: PMC12001674.
REVISION-PCP 